Physical therapy management of Pompe disease (Q36479980)

14 August 2017

1 reference

title

Physical therapy management of Pompe disease (English)

1 reference

14 August 2017

Laura Elizabeth Case

1

1 reference

14 August 2017

Priya Sunil Kishnani

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

8

1 reference

14 August 2017

318-327

1 reference

14 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1097/01.gim.0000217789.14470.c5

14 August 2017

0 references

cites work

Pompe disease in infants and children

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Lysosomal dysfunction in muscle with special reference to glycogen storage disease type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Efficacy of multidisciplinary approach in the treatment of two cases of nonclassical infantile glycogenosis type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Protein turnover in acid maltase deficiency before and after treatment with a high protein diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

The effect of a high protein diet on leucine and alanine turnover in acid maltase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Impaired performance of skeletal muscle in alpha-glucosidase knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Clinical variability in adult-onset acid maltase deficiency: report of affected sibs and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Role of physical activity and exercise training in neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Developmental biomechanics. Effect of forces on the growth, development, and maintenance of the human body.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

For how long must the soleus muscle be stretched each day to prevent contracture?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Neonatal spinal muscular atrophy with multiple contractures, bone fractures, respiratory insufficiency and 5q13 deletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

The emerging role of the pediatric physical therapist in evaluation and intervention for individuals with lysosomal storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Benign course of glycogen storage disease type IIb in two brothers: nature or nurture?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

A randomized comparative study of two methods for controlling Tendo Achilles contracture in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Low magnitude mechanical loading is osteogenic in children with disabling conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

Muscle MRI in adult-onset acid maltase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000217789.14470.C5

10.1097/01.GIM.0000217789.14470.C5

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference